Clinical Trial Update: A Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment of Premature Ejaculation [Phase 1]

View source ↗

Summary

Phase 1 trial completed evaluating safety and tolerability of PSD502, a topical anesthetic, for treating premature ejaculation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ejaculation

Drugs mentioned

• PSD502

Snippet

Sponsor: Plethora Solutions Ltd | Conditions: Premature Ejaculation | Phase 1 | Status: COMPLETED